Guided Bone Regeneration Using Fixed vs Non-Fixed Resorbable Collagen Membranes
Launched by UNIVERSITAT INTERNACIONAL DE CATALUNYA · Mar 20, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different ways to help rebuild bone in the jaw so that dental implants can be placed. The researchers want to find out if using a type of collagen membrane that is fixed in place provides better bone growth compared to a membrane that is not fixed. Both groups will receive a bone substitute, and the goal is to see how much bone is gained after six months.
To participate, you need to be at least 18 years old and have a narrow ridge of bone (less than or equal to 5mm) in your jaw that needs treatment before you can get dental implants. You should also have enough height in your jawbone and be missing one or more back teeth. It's important that you don’t have active gum disease, certain health conditions, or heavy smoking habits. If you join the trial, you can expect regular check-ups to monitor your progress. This study is currently recruiting participants, and both men and women are welcome to apply.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Men and women over 18 years old or older
- • 2. Patients requiring Guided Bone Regeneration due to insufficient ridge width(≤5mm) to place dental implants, with sufficient vertical ridge height (≥9mm) from vital anatomical structures (the inferior alveolar nerve in the Mandible, or the sinus in the Maxilla)
- • 3. One or more teeth missing in posterior zone (Premolars, and Molars)
- • 4. Absence of active Periodontal disease
- • 5. Good level of oral hygiene (Plaque index \<25%)
- • 6. Absence of systemic diseases that could influence the outcome of the therapy (Uncontrolled diabetes, osteoporosis, bisphosphonate medications)
- • 7. Non smokers or light smokers (\<10 cigarettes per day)
- • 8. Informed consent signed
- Exclusion Criteria:
- • 1. Patients with sufficient ridge width (\>5 mm) and height (≥9mm) from vital anatomical structure) requiring no GBR to place dental implants
- • 2. Patients with severe horizontal and vertical defects requiring other surgical techniques.
- • 3. Long-term non-steroidal anti-inflammatory drug therapy (3months).
- • 4. Lactating females or currently pregnant women.
- • 5. Severe cognitive or psychiatric disorders.
- • 6. Unwillingness to return for follow-up examination.
About Universitat Internacional De Catalunya
The Universitat Internacional de Catalunya (UIC) is a prestigious higher education institution situated in Barcelona, Spain, renowned for its commitment to academic excellence and innovation in research. With a strong emphasis on interdisciplinary collaboration, UIC actively engages in clinical trials that aim to advance medical knowledge and improve patient outcomes. The university's dedicated research teams are equipped with cutting-edge facilities and experienced professionals, enabling them to conduct rigorous studies across various health-related fields. UIC's focus on ethical practices and compliance ensures that all clinical trials are conducted with the highest standards of scientific integrity and participant safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barcelona, Sant Cugat Del Vallès, Spain
Barcelona, , Spain
Patients applied
Trial Officials
Cristina Vallés, DDS, MS, PhD
Principal Investigator
Universitat Internacional de Catalunya
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported